S. Bretti

1.5k total citations
33 papers, 1.3k citations indexed

About

S. Bretti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, S. Bretti has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 4 papers in Hematology. Recurrent topics in S. Bretti's work include Lung Cancer Treatments and Mutations (8 papers), Cancer Treatment and Pharmacology (5 papers) and Lung Cancer Research Studies (4 papers). S. Bretti is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer Treatment and Pharmacology (5 papers) and Lung Cancer Research Studies (4 papers). S. Bretti collaborates with scholars based in Italy, United Kingdom and Switzerland. S. Bretti's co-authors include Maria Flavia Di Renzo, Martina Olivero, Silvia Giordano, Paolo M. Comoglio, Enzo Médico, Radha P. Narsimhan, P Gaglia, Arianna Giacomini, Bernard Nordlinger and Eric Chastre and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer.

In The Last Decade

S. Bretti

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Bretti Italy 13 552 449 391 250 233 33 1.3k
Marilyn M. Giacomini United States 7 233 0.4× 340 0.8× 247 0.6× 160 0.6× 206 0.9× 8 1.0k
A. Frilling Germany 21 245 0.4× 392 0.9× 463 1.2× 427 1.7× 103 0.4× 60 1.3k
Ningling Ge China 20 708 1.3× 323 0.7× 505 1.3× 270 1.1× 200 0.9× 44 1.4k
Pramila Ramani United Kingdom 21 129 0.2× 533 1.2× 276 0.7× 477 1.9× 308 1.3× 48 1.4k
Beate Häberle Germany 18 286 0.5× 486 1.1× 254 0.6× 336 1.3× 71 0.3× 42 1.1k
Michiyoshi Hisanaga Japan 22 475 0.9× 439 1.0× 632 1.6× 691 2.8× 213 0.9× 55 1.7k
Hironori Kusano Japan 15 228 0.4× 171 0.4× 247 0.6× 184 0.7× 164 0.7× 67 721
Dulabh Monga United States 15 158 0.3× 396 0.9× 539 1.4× 277 1.1× 227 1.0× 74 1.1k
P Gaglia Italy 10 441 0.8× 362 0.8× 332 0.8× 215 0.9× 98 0.4× 17 891
Takehiro Hayashi Japan 15 279 0.5× 394 0.9× 333 0.9× 125 0.5× 126 0.5× 44 937

Countries citing papers authored by S. Bretti

Since Specialization
Citations

This map shows the geographic impact of S. Bretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Bretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Bretti more than expected).

Fields of papers citing papers by S. Bretti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Bretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Bretti. The network helps show where S. Bretti may publish in the future.

Co-authorship network of co-authors of S. Bretti

This figure shows the co-authorship network connecting the top 25 collaborators of S. Bretti. A scholar is included among the top collaborators of S. Bretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Bretti. S. Bretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ridolfi, Ruggero, Roberto Labianca, Stefano Palazzo, et al.. (2015). Circulating microRNAs (miRNAs): Biomarkers for Lung Cancer. Annals of Oncology. 26. vi146–vi146. 1 indexed citations
2.
Filosso, Pier Luigi, Sofia Asioli, Enrico Ruffini, et al.. (2008). Radical resection of a giant, invasive and symptomatic malignant Solitary Fibrous Tumour (SFT) of the pleura. Lung Cancer. 64(1). 117–120. 15 indexed citations
3.
Castagneto, B., et al.. (2005). Cisplatin and Gemcitabine in Malignant Pleural Mesothelioma: A Phase II Study. American Journal of Clinical Oncology. 28(3). 223–226. 44 indexed citations
4.
Donadio, Michela, Mara Ardine, Alfredo Berruti, et al.. (2005). Weekly Cisplatin plus Capecitabine in Metastatic Breast Cancer Patients Heavily Pretreated with both Anthracycline and Taxanes. Oncology. 69(5). 408–413. 11 indexed citations
5.
Filosso, Pier Luigi, et al.. (2004). Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): Report of a successful case and review of the literature. Journal of Thoracic and Cardiovascular Surgery. 127(4). 1215–1219. 27 indexed citations
6.
Bretti, S., Alfredo Berruti, Paola Sperone, et al.. (2003). Multimodal management of stages III–IVa malignant thymoma. Lung Cancer. 44(1). 69–77. 81 indexed citations
7.
Parrà, Héctor Soto, Lucia Tixi, S. Bretti, et al.. (2001). Combined regimen of cisplatin, doxorubicin, and ?-2b interferon in the treatment of advanced malignant pleural mesothelioma. Cancer. 92(3). 650–656. 41 indexed citations
8.
9.
Bretti, S., Alfredo Berruti, Luigi Dogliotti, et al.. (1998). Combined Epirubicin and Interleukin-2 Regimen in the Treatment of Malignant Mesothelioma: A Multicenter Phase II Study of the Italian Group on Rare Tumors. Tumori Journal. 84(5). 558–561. 17 indexed citations
10.
Bretti, S., Maria Gilleece, M.G. Rowlands, et al.. (1996). An open phase I study to assess the biological effects of a continuous intravenous infusion of interleukin-3 followed by granulocyte macrophage-colony stimulating factor. European Journal of Cancer. 32(7). 1171–1178. 4 indexed citations
11.
Bretti, S., Alfredo Berruti, G. Gorzegno, et al.. (1996). Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients. Lung Cancer. 14(2-3). 353–360. 14 indexed citations
12.
Clerici, M., S. Bretti, Alessandro Comandone, et al.. (1995). Non small cell lung cancer treatment with vinorelbine monochemotherapy: A phase II study. Lung Cancer. 13(2). 218–218. 4 indexed citations
13.
Comandone, Alessandro, et al.. (1995). Stability of ifosfamide in solutions for multiday infusion by external pump. Anti-Cancer Drugs. 6(4). 604–607. 8 indexed citations
14.
15.
Comandone, Alessandro, et al.. (1994). Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment.. PubMed. 13(5C). 1781–3. 29 indexed citations
16.
Aglietta, Massimo, F Sanavio, Alessandra Stacchini, et al.. (1993). Interleukin-3 in vivo: kinetic of response of target cells. Blood. 82(7). 2054–2061. 5 indexed citations
17.
Comandone, Alessandro, et al.. (1992). [Metastasis to the penis from carcinoma of the rectum. A clinical case].. PubMed. 38(1). 49–52. 7 indexed citations
18.
Bretti, S., Paolo Neri, Luisa Lozzi, et al.. (1989). Inhibition of experimental metastasis of murine fibrosarcoma cells by oligopeptide analogues to the fibronectin cell‐binding site. International Journal of Cancer. 43(1). 102–106. 6 indexed citations
19.
Prat, María, et al.. (1988). The Monoclonal Antibody-defined CAR-3 Antigen is a Serological Marker Associated with Pancreatic Carcinoma. The International Journal of Biological Markers. 3(1). 29–35. 8 indexed citations
20.
Renzo, Maria Flavia Di & S. Bretti. (1982). Characterization of stable spontaneous metastatic variant lines of RSV‐transformed mouse fibroblasts. International Journal of Cancer. 30(6). 751–757. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marilyn M. Giacomini Breakdown of academic impact, for papers by A. Frilling Breakdown of academic impact, for papers by Ningling Ge Breakdown of academic impact, for papers by Pramila Ramani Breakdown of academic impact, for papers by Beate Häberle Breakdown of academic impact, for papers by Michiyoshi Hisanaga Breakdown of academic impact, for papers by Hironori Kusano Breakdown of academic impact, for papers by Dulabh Monga Breakdown of academic impact, for papers by P Gaglia Breakdown of academic impact, for papers by Takehiro Hayashi
Rankless by CCL
2026